This inventor holds 2 USPTO granted patents and 4 published patent applications and 1 EPO patent. Top assignee: Genentech, Inc.. Active years: 2015-2018.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2015-2018
Title: Arundhati Sengupta-Ghosh: Innovator in Neurological Treatments
Introduction
Arundhati Sengupta-Ghosh is a prominent inventor based in Union City, CA (US). She has made significant contributions to the field of neurological disorders and nervous system injuries. With a total of 2 patents, her work focuses on innovative treatments that aim to improve the quality of life for individuals affected by these conditions.
Latest Patents
One of her latest patents is titled "Modulation of Axon Degeneration." This invention relates generally to the treatment of neurological disorders and nervous system injuries. Specifically, it provides methods of using modulators of particular target proteins to modulate the degeneration of neurons or portions thereof, such as axons. This groundbreaking work has the potential to change the landscape of treatment options available for patients suffering from neurological issues.
Career Highlights
Throughout her career, Arundhati has worked with leading companies in the pharmaceutical and biotechnology sectors. Notably, she has been associated with Genentech, Inc. and F. Hoffmann-La Roche AG. Her experience in these organizations has allowed her to develop and refine her innovative ideas, contributing to her success as an inventor.
Collaborations
Arundhati has collaborated with several talented individuals in her field. Some of her notable coworkers include Ryan Jefferson Watts and Mark Chen. These collaborations have fostered a creative environment that has led to the development of her impactful inventions.
Conclusion
Arundhati Sengupta-Ghosh is a trailblazer in the field of neurological treatments, with her innovative patents paving the way for new therapeutic approaches. Her dedication to improving patient outcomes through her inventions is commendable and highlights the importance of innovation in healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
